<?xml version="1.0" encoding="UTF-8"?>
<p>China has already announced that it has a vaccine clinical trials. The potential candidate is realized by the Military Academy of Medical Sciences of China and Cansino Biologics and is based on a technological platform developed by Cansino, related to viral adenoviruses. It is the same platform where a vaccine for Ebola was successful in 2017 (
 <xref rid="B95" ref-type="bibr">95</xref>).
</p>
